دورية أكاديمية
أعرض في EDS

A 2.5-Year Weight Management Program Using Noom Health: Protocol for a Randomized Controlled Trial.

التفاصيل البيبلوغرافية
العنوان: A 2.5-Year Weight Management Program Using Noom Health: Protocol for a Randomized Controlled Trial.
المؤلفون: Sysko R; Eating and Weight Disorders Program, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Bibeau J; Eating and Weight Disorders Program, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Boyar A; Eating and Weight Disorders Program, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Costello K; Eating and Weight Disorders Program, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Michaelides A; Noom Inc, New York, NY, United States., Mitchell ES; Noom Inc, New York, NY, United States., Susanin A; Eating and Weight Disorders Program, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Hildebrandt T; Eating and Weight Disorders Program, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
المصدر: JMIR research protocols [JMIR Res Protoc] 2022 Aug 12; Vol. 11 (8), pp. e37541. Date of Electronic Publication: 2022 Aug 12.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: JMIR Publications Country of Publication: Canada NLM ID: 101599504 Publication Model: Electronic Cited Medium: Print ISSN: 1929-0748 (Print) Linking ISSN: 19290748 NLM ISO Abbreviation: JMIR Res Protoc Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Toronto : JMIR Publications
مستخلص: Background: Overweight and obesity are serious public health concerns. As the prevalence of excess weight among individuals continues to increase, there is a parallel need for inexpensive, highly accessible, and evidence-based weight loss programs.
Objective: This weight loss trial will aim to examine the efficacy of the Noom weight loss program in comparison to a digital control after a 6-month intervention phase and a 24-month maintenance phase, with assessments continuing for 2 years beyond the intervention (to 30 months-after the baseline). The secondary outcomes include quality of life, psychosocial functioning, sleep quality, physical activity, diet, and health status. This trial will also examine the severity of obesity-related functional impairment, weight loss history, and demographic moderators, along with adherence and self-efficacy as mediators of the outcome.
Methods: A total of 600 participants were randomized in a parallel-group, controlled trial to either Noom Healthy Weight Program (intervention) or Noom Healthy Weight Control (control) for a 6-month intervention. Both intervention and control groups include diet and exercise recommendations, educational content, daily logging capabilities, and daily weigh-in entries. The Noom Healthy Weight Program also includes a coach support for weight loss. Remote follow-up assessments of eating, physical activity, psychosocial factors, app use data, and weight will be conducted at 1, 4, 6, 12, 18, 24, and 30 months after baseline. Weight is measured at each follow-up point during a Zoom call using the participants' scales.
Results: Enrollment began in March 2021 and the 6-month intervention phase ended in March 2022. Data collection for the final assessment will be completed in March 2024.
Conclusions: This study tests commercially available digital lifestyle interventions for individuals with overweight and obesity seeking weight loss support. Data obtained from the study will evaluate whether the Noom Healthy Weight Control Program can help individuals overcome weight loss, achieve long-term maintenance, adhere to lifestyle changes, and feature use barriers that are present in other traditional weight loss treatments.
Trial Registration: ClinicalTrials.gov NCT04797169; https://clinicaltrials.gov/ct2/show/NCT04797169.
International Registered Report Identifier (irrid): DERR1-10.2196/37541.
(©Robyn Sysko, Jessica Bibeau, Allison Boyar, Kayla Costello, Andreas Michaelides, Ellen Siobhan Mitchell, Annabel Susanin, Tom Hildebrandt. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 12.08.2022.)
References: Am J Clin Nutr. 2005 Jul;82(1 Suppl):222S-225S. (PMID: 16002825)
Adv Nutr. 2011 Jul;2(4):368-9. (PMID: 22332078)
Telemed J E Health. 2019 Feb;25(2):85-92. (PMID: 29847222)
Telemed J E Health. 2020 Mar;26(3):365-368. (PMID: 30994410)
Behav Sleep Med. 2011 Dec 28;10(1):6-24. (PMID: 22250775)
Behav Res Ther. 2021 Jun;141:103850. (PMID: 33839586)
Health Psychol Rev. 2020 Mar;14(1):132-144. (PMID: 31957557)
Scand J Psychol. 2021 Aug;62(4):574-585. (PMID: 34060091)
Behav Res Methods. 2018 Oct;50(5):2125-2143. (PMID: 29247385)
J Diabetes Res. 2017;2017:2615681. (PMID: 28890899)
Am J Prev Med. 2021 Oct;61(4):606-617. (PMID: 34544560)
Psychiatr Clin North Am. 2011 Dec;34(4):717-32. (PMID: 22098799)
J Biomed Inform. 2009 Apr;42(2):377-81. (PMID: 18929686)
J Med Internet Res. 2019 Jun 21;21(6):e14265. (PMID: 31228174)
Ann Intern Med. 2005 Aug 16;143(4):251-64. (PMID: 16103469)
JMIR Mhealth Uhealth. 2016 Jul 26;4(3):e87. (PMID: 27460502)
J Health Commun. 2017 May;22(5):395-402. (PMID: 28339324)
Digit Health. 2020 Nov 30;6:2055207620976755. (PMID: 33294209)
Exp Gerontol. 2022 Aug;165:111837. (PMID: 35598698)
J Am Diet Assoc. 2007 Jun;107(6):1002-7. (PMID: 17524721)
J Cardiovasc Nurs. 2009 Jan-Feb;24(1):58-80. (PMID: 19114803)
Int J Med Inform. 2016 Oct;94:81-90. (PMID: 27573315)
JMIR Mhealth Uhealth. 2019 Feb 28;7(2):e12209. (PMID: 30816851)
Prev Med. 2016 Nov;92:51-57. (PMID: 27095323)
Obesity (Silver Spring). 2014 Jul;22 Suppl 2:S5-39. (PMID: 24961825)
JMIR Mhealth Uhealth. 2018 May 03;6(5):e93. (PMID: 29724709)
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95. (PMID: 12900694)
Obes Rev. 2010 Apr;11(4):306-21. (PMID: 19754633)
Lancet Diabetes Endocrinol. 2014 Dec;2(12):954-62. (PMID: 25459211)
J Behav Med. 2019 Apr;42(2):365-375. (PMID: 30311111)
Assessment. 2009 Mar;16(1):16-30. (PMID: 18703821)
Am J Prev Med. 2013 Nov;45(5):576-82. (PMID: 24139770)
J Am Diet Assoc. 2011 Jan;111(1):92-102. (PMID: 21185970)
Obesity (Silver Spring). 2020 Mar;28(3):521-528. (PMID: 32030910)
Diabetes Care. 2002 Dec;25(12):2165-71. (PMID: 12453955)
Obes Res. 1995 May;3(3):241-8. (PMID: 7627772)
Diabetes Care. 2007 Jun;30(6):1374-83. (PMID: 17363746)
Sci Rep. 2016 Nov 07;6:34563. (PMID: 27819345)
J Nutr Educ Behav. 2021 Sep;53(9):732-741. (PMID: 34315678)
Annu Rev Nutr. 2001;21:323-41. (PMID: 11375440)
Multivariate Behav Res. 2013 May;48(3):370-97. (PMID: 26741847)
Health Promot Perspect. 2020 Jul 12;10(3):230-237. (PMID: 32802759)
Med Care. 1992 Jun;30(6):473-83. (PMID: 1593914)
Obesity (Silver Spring). 2007 Dec;15(12):3091-6. (PMID: 18198319)
Contemp Clin Trials. 2021 Jan;100:106217. (PMID: 33197609)
Prev Med. 2010 Aug;51(2):123-8. (PMID: 20478333)
Stat Med. 2013 May 20;32(11):1964-73. (PMID: 23303653)
Health Psychol. 2000 Jan;19(1S):5-16. (PMID: 10709944)
Am J Prev Med. 2018 Nov;55(5):583-591. (PMID: 30262149)
Obes Res Clin Pract. 2017 Mar - Apr;11(2):206-214. (PMID: 27292942)
Obes Rev. 2005 Feb;6(1):67-85. (PMID: 15655039)
Obes Rev. 2016 Sep;17(9):895-906. (PMID: 27192162)
Am J Psychiatry. 2016 Jul 1;173(7):672-9. (PMID: 26988629)
Ann Intern Med. 2014 Nov 18;161(10 Suppl):S5-12. (PMID: 25402403)
Am J Psychiatry. 2020 Feb 1;177(2):134-142. (PMID: 32008396)
Struct Equ Modeling. 2008;15(1):23-51. (PMID: 20179778)
Nutrients. 2020 Jul 03;12(7):. (PMID: 32635174)
JMIR Mhealth Uhealth. 2018 Jun 20;6(6):e145. (PMID: 29925496)
معلومات مُعتمدة: UL1 TR004419 United States TR NCATS NIH HHS
فهرسة مساهمة: Keywords: DPP; Diabetes Prevention Program; Noom; digital health; mobile phone; weight loss; weight loss maintenance
سلسلة جزيئية: ClinicalTrials.gov NCT04797169
تواريخ الأحداث: Date Created: 20220815 Latest Revision: 20240904
رمز التحديث: 20240904
مُعرف محوري في PubMed: PMC9419047
DOI: 10.2196/37541
PMID: 35969439
قاعدة البيانات: MEDLINE
الوصف
تدمد:1929-0748
DOI:10.2196/37541